Effectiveness of brodalumab in improving itching and skin pain in Japanese patients with psoriasis: The <scp>ProLOGUE</scp> study-Reference-Cited by-同舟云学术

Effectiveness of brodalumab in improving itching and skin pain in Japanese patients with psoriasis: The ProLOGUE study

Published:2022-12-20 Issue:4 Volume:50 Page:453-461
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:The Journal of Dermatology

Author:

Honma Masaru¹^ORCID,Kanai Yasumasa²,Murotani Kenta³,Ito Kei⁴,Ohata Chika⁵^ORCID,Yamazaki Fumikazu⁶^ORCID,Saeki Hidehisa⁷^ORCID,Seishima Mariko⁸^ORCID,Mizutani Yoko⁸^ORCID,Kitabayashi Hiroki²,Imafuku Shinichi⁹^ORCID

Affiliation:

1. Department of Dermatology Asahikawa Medical University Asahikawa Japan

2. Medical Affairs Kyowa Kirin Co., Ltd. Tokyo Japan

3. Biostatistics Center Kurume University Kurume Japan

4. Department of Dermatology JR Sapporo Hospital Sapporo Japan

5. Department of Dermatology Osaka General Medical Center Osaka Japan

6. Department of Dermatology Kansai Medical University Osaka Japan

7. Department of Dermatology Nippon Medical School Tokyo Japan

8. Department of Dermatology Gifu University Graduate School of Medicine Gifu Japan

9. Department of Dermatology Fukuoka University Faculty of Medicine Fukuoka Japan

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1346-8138.16682

Reference31 articles.

1. Global burden of psoriasis – comparison of regional and global epidemiology, 1990 to 2017

2. A multicenter, non-interventional study to evaluate patient-reported experiences of living with psoriasis

3. Itch: an under‐recognized problem in psoriasis

4. Psoriasis and Skin Pain: Instrumental and Biological Evaluations

5. Skin pain and skin discomfort is associated with quality of life in patients with psoriasis

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and emerging drugs for the treatment of pruritus: an update of the literature;Expert Opinion on Pharmacotherapy;2024-04-12